中航高科(600862.SH):子公司擬與航空工業製造院簽署先進航空複合材料系列預浸料技術實施許可協議
格隆匯12月29日丨中航高科(600862.SH)公佈,為進一步增強公司核心主業競爭優勢,促進科技成果產業化,經公司認真研究並充分論證,公司全資子公司航空工業復材擬與股東方航空工業製造院簽署《先進航空複合材料系列預浸料技術實施許可協議》(許可期限為2022年度)。根據《協議》約定,航空工業復材可在航空工業製造院許可期限內利用許可技術製造及銷售許可產品。
技術實施許可費總額不得超過人民幣1.8億元(含税)。
本次與航空工業製造院簽訂《先進航空複合材料系列預浸料技術實施許可協議》是A系列樹脂和B系列樹脂、國產T800H級碳纖維系列預浸料等14種新產品產業化的里程碑,是進一步增強公司核心主業競爭優勢,促進科技成果產業化的有效措施,符合交易雙方業務發展需求和商業規則。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.